Objective:To systematically identify and summarize the best available evidence on feeding management during the peridischarge period for very low birth weight infants (VLBWI) and extremely low birth weight infants (ELBWI), providing a reference for clinical nursing practice.Methods:Evidence on feeding management for VLBWI/ELBWI during the peridischarge period was retrieved from decision support systems, guideline repositories, major databases, and relevant professional organizations' websites. Sources included clinical decisions, guidelines, evidence summaries, systematic reviews, expert consensus documents and so on. The search spanned from database inception to April 2024. Guidelines were reviewed by four researchers, while other documents were screened and appraised by two researchers.Results:A total of 24 documents were included: six clinical decision tools, four guidelines, three systematic reviews, three evidence summaries, and eight expert consensus statements. A total of three primary themes, 10 secondary themes, and 49 best evidence items were synthesized. These covered: pre-discharge feeding management (establishing a peridischarge feeding team, parental feeding education, assessing feeding status of VLBWI/ELBWI, evaluating parental feeding competence, preparing feeding materials/environment and assessing community resources) ; discharge feeding management (providing feeding-related medical records and developing individualized feeding plans) ; post-discharge feeding management (setting growth and development goals, conducting follow-up and growth monitoring, and supplementing necessary nutrients) .Conclusions:The summarized best evidence provides a practical reference for healthcare professionals to effectively implement feeding management for VLBWI/ELBWI during the peridischarge period. Evidence-based strategies should be selectively applied in clinical practice based on individual conditions to ensure a successful transition to home feeding and support healthy growth and development of VLBWI/ELBWI.

Objective:To systematically identify and summarize the best available evidence on feeding management during the peridischarge period for very low birth weight infants (VLBWI) and extremely low birth weight infants (ELBWI), providing a reference for clinical nursing practice.Methods:Evidence on feeding management for VLBWI/ELBWI during the peridischarge period was retrieved from decision support systems, guideline repositories, major databases, and relevant professional organizations' websites. Sources included clinical decisions, guidelines, evidence summaries, systematic reviews, expert consensus documents and so on. The search spanned from database inception to April 2024. Guidelines were reviewed by four researchers, while other documents were screened and appraised by two researchers.Results:A total of 24 documents were included: six clinical decision tools, four guidelines, three systematic reviews, three evidence summaries, and eight expert consensus statements. A total of three primary themes, 10 secondary themes, and 49 best evidence items were synthesized. These covered: pre-discharge feeding management (establishing a peridischarge feeding team, parental feeding education, assessing feeding status of VLBWI/ELBWI, evaluating parental feeding competence, preparing feeding materials/environment and assessing community resources) ; discharge feeding management (providing feeding-related medical records and developing individualized feeding plans) ; post-discharge feeding management (setting growth and development goals, conducting follow-up and growth monitoring, and supplementing necessary nutrients) .Conclusions:The summarized best evidence provides a practical reference for healthcare professionals to effectively implement feeding management for VLBWI/ELBWI during the peridischarge period. Evidence-based strategies should be selectively applied in clinical practice based on individual conditions to ensure a successful transition to home feeding and support healthy growth and development of VLBWI/ELBWI.

Objective:To explore the effects of age,period and cohort on the incidence of endometriosis(EMT)and disability adjusted life year(DALY)in China from 1990 to 2019.Methods:Using the Global Burden of Disease(GBD)2019 database,the incidence of EMT and DALY in China from 1990 to 2019 were analyzed.The time variation trend of standardized incidence and standardized DALY rate was analyzed with Joinpoint 4.8.0.1 software,and the average annual percentage change was calculated.The age-period-cohort model was construc-ted to analyze the effect of age,period and birth cohort on the incidence of endometriosis and DALY trend change.Results:In 2019,the incidence of EMT in China was 72.61/100,000,and the DALY rate was 47.38/100,000.The incidence rate and DALY rate were 39.71％and 24.97％lower than those in 1990.From 1990 to 2019,the standardized incidence rate and standardized DALY rate of EMT in China showed a downward trend,with an an-nual decrease of 1.02％and 1.00％respectively,with statistical significance(P＜0.05).The results of age effect showed that the overall incidence of EMT in China showed was decreasing,and the DALY rate was increasing from 15 to 29 years old,and then decreased after 30 years old.The results of period effect showed that the relative ratio(RR)of EMT incidence risk and DALY risk in China showed a decreasing trend.Taking the period from 2000 to 2004 as the reference group,the incidence risk(RR 1.78,95％CI 1.64-1.95)and DALY risk(RR 1.05,95％CI 0.90-1.23)were the highest in 1990-1994.The results of cohort effect showed that the later people were born,the lower the risk of EMT was.Conclusions:From 1990 to 2019,the standardized incidence rate and standardized DALY rate of EMT in China showed a downward trend.The epidemiological patterns and trends of EMT in differ-ent ages,periods and birth cohorts may provide new insights for public health,and provide an important basis for formulating public health strategies to further reduce the burden of EMT.

Objective:To explore the effects of age,period and cohort on the incidence of endometriosis(EMT)and disability adjusted life year(DALY)in China from 1990 to 2019.Methods:Using the Global Burden of Disease(GBD)2019 database,the incidence of EMT and DALY in China from 1990 to 2019 were analyzed.The time variation trend of standardized incidence and standardized DALY rate was analyzed with Joinpoint 4.8.0.1 software,and the average annual percentage change was calculated.The age-period-cohort model was construc-ted to analyze the effect of age,period and birth cohort on the incidence of endometriosis and DALY trend change.Results:In 2019,the incidence of EMT in China was 72.61/100,000,and the DALY rate was 47.38/100,000.The incidence rate and DALY rate were 39.71％and 24.97％lower than those in 1990.From 1990 to 2019,the standardized incidence rate and standardized DALY rate of EMT in China showed a downward trend,with an an-nual decrease of 1.02％and 1.00％respectively,with statistical significance(P＜0.05).The results of age effect showed that the overall incidence of EMT in China showed was decreasing,and the DALY rate was increasing from 15 to 29 years old,and then decreased after 30 years old.The results of period effect showed that the relative ratio(RR)of EMT incidence risk and DALY risk in China showed a decreasing trend.Taking the period from 2000 to 2004 as the reference group,the incidence risk(RR 1.78,95％CI 1.64-1.95)and DALY risk(RR 1.05,95％CI 0.90-1.23)were the highest in 1990-1994.The results of cohort effect showed that the later people were born,the lower the risk of EMT was.Conclusions:From 1990 to 2019,the standardized incidence rate and standardized DALY rate of EMT in China showed a downward trend.The epidemiological patterns and trends of EMT in differ-ent ages,periods and birth cohorts may provide new insights for public health,and provide an important basis for formulating public health strategies to further reduce the burden of EMT.

Objective To investigate the value of ultrasonography in the diagnosis and treatment of caesarean scar pregnancy (CSP) after cesarean section,so as to help clinicians to select proper treatment methods and evaluate therapeutic effects.Methods Retrospective analysis on the clinical data and ultrasonographic features of 27 cases of CSP which were diagnosed by ultrasonography and clinically confirmed in our department from August 2012 to August 2014 was made for the study.Results According to the ultrasonographic features,the cases in the group were divided into the gestational sac type (17 cases) (with a diagnostic accordance rate of 88％) and the mass type (10 cases) (with a diagnose accordance rate of 80％).Total diagnose accordance rate was 85％.After treatment,the sizes of foci,blood flow andβ-HCG values were all decreased.Conclusion Ultrasonography is of important value for the diagnosis of caesarean scar pregnancy after cesarean section,and can help clinicians to select better treatment methods and evaluate therapeutic effects.

Objective In this study,we employed newborn hearing screening and gene screening concurrently to explore the hearing loss associated with mutations in the city of Jinan.Methods A total of 3 288 newborns born between March 2013 and December 2013 in Jinan Maternity and Child Care Hospital received hearing concurrent genetic screening.Transiently evoked otoacoustic emissions (TEOAE) was used in rooming-in newborns,while TEOAE and auto auditory brainstem response (AABR) was used in infants in neonatal intensive care unit (NICU).Two drops of heel blood were harvested with filter paper.Nine mutations [GJB2(235delC,35delG,299delAT,176del16),SLC26A4(IVS7-2A ＞ G,2168 A ＞ G),GJB3 (538 C ＞ T),12SrRNA (1555 A ＞ G,1494C ＞ T)] of 4 frequent genes associated with Chinese hearing loss were determined by gene chip in these dried blood samples.Results Among 3 288 newborns,363 cases failed to pass the hearing screening,and 36 cases of these 363 newborns carried mutations,with a carrier rate of 9.91％.2 925 cases passed the hearing screening,of which 113 carried mutations,with a carrier rate of 3.86％.There was a significantly statistic difference (x2 =8.67,P =0.000) in carrier rate between two groups.149(4.53％) infants were detected to carry at least one mutation allele,among which 113 cases passed the hearing screening and 36 cases failed.Seven cases were diagnosed to have hearing loss.Homozygous GJB2 mutation was detected in 2 cases,compound heterozygous GJB2 mutation was detected in 1 case,and heterozygous GJB2 mutation in 88 cases.There were 91 cases carried GJB2 mutations totally,with a total rate of 2.76％.There were 40 cases were detected to carry heterozygous SLC26A4 mutation,with a carrier rate of 1.22％.Nine cases had heterozygous GJB3 mutation,with a carrier rate of 0.27％.Six cases had homogeneous mitochondria 12SrRNA mutation,and 1 had heterogeneous mutations.There were 7 cases totally,with a total rate of 0.21％.142 infants with gene mutation should be follow-up.Conclusion A follow-up system in infants,passed hearing screening,with single heterozygous mutation and mutations associated with drug-induced hearing loss,can help to detect infants with hearing defects early and effectively prevent late-onset hearing impairment.

To investigate the high-risk factors for newborn hearing loss and to provide information for preventing the development of hearing loss and delaying its progression, from May 2003 to June 2006, neonates who failed to pass the universal newborn hearing screening (UNHS) were referred to Jinan Newborn Hearing Screening and Rehabilitation Center from 7 newborn hearing screening centers in seven cities of Shandong province. One-to-one pair-matched case-control method was employed for statistical analysis of the basic features of definitely identified cases. High-risk factors relating to the bilateral hearing loss were evaluated by univariate and multivariate Logistic regression analysis. Our results revealed that 721 transferred newborns who didn't pass the hearing screening received audiological and medical evaluation and 367 were confirmed to have hearing loss. Of them, 177 neonates with hearing loss who met the matching requirements were included in the study as subjects. Univariate analysis showed that high-risk factors related to hearing loss incuded age of father, education backgrounds of parents, parity, birth weight, gestational weeks, craniofacial deformity, history of receiving treatment in neonatal intensive care unit (NICU), neonatal disease, family history of otopathy and family history of congenital hearing loss. Multivariate Logistic regression analysis revealed that 4 independent risk factors were related to bilateral hearing loss, including parity (OR=16.285, 95% CI 3.379-78.481), neonatal disease (OR=34.968, 95% CI 2.720-449.534), family history of congenital hearing loss (OR=69.488, 95% CI 4.417-1093.300) and birth weight (OR=0.241, 95% CI 0.090-0.648). It is concluded that parity, neonatal disease and family history of hearing loss are the promoting factors of bilateral hearing loss in neonates and appropriate intervention measures should be taken to deal with the risk factors.

To investigate the high-risk factors for newborn heating loss and to provide information for preventing the development of hearing loss and delaying its progression, from May 2003 to June 2006, neonates who failed to pass the universal newborn hearing screening (UNHS) were referred to Jinan Newborn Hearing Screening and Rehabilitation Center from 7 newborn heating screening centers in seven cities of Shandong province. One-to-one pair-matched case-control method was employed for statistical analysis of the basic features of definitely identified cases. High-risk factors relating to the bilateral hearing loss were evaluated by univariate and multivariate Logistic regression analysis. Our results revealed that 721 transferred newborns who didn't pass the heating screening received audiological and medical evaluation and 367 were confirmed to have heating loss. Of them,177 neonates with heating loss who met the matching requirements were included in the study as subjects. Univariate analysis showed that high-risk factors related to hearing loss incuded age of father, education backgrounds of parents, parity, birth weight, gestational weeks, craniofacial deformity,history of receiving treatment in neonatal intensive care unit (NICU), neonatal disease, family history of otopathy and family history of congenital hearing loss. Multivariate Logistic regression analysis revealed that 4 independent risk factors were related to bilateral hearing loss, including parity (OR=16.285, 95% CI 3.379-78.481), neonatal disease (OR=34.968, 95% CI 2.720-449.534),family history of congenital hearing loss (OR=69.488, 95% CI 4.417-1093.300) and birth weight (OR=0.241, 95% CI 0.090-0.648). It is concluded that parity, neonatal disease and family history of hearing loss are the promoting factors of bilateral hearing loss in neonates and appropriate intervention measures should be taken to deal with the risk factors.

Multiple kinds of Artificial Skin Substitute are now available. However, except for the Homo Skin Graft there is no Artificial Skin Substitute that can be used as permanent Artificial Skin Substitute. During the past 20 years, more and more scholars around the world have expressed increased interests in the research and development of Artificial Skin Graft that can be utilized as satisfying permanent Artificial Skin Substitute. We conducted our research on the biological evaluation of medical devices of Collagen-Chitosan(C-C) Artificial Skin Substitute according to the National Standard (GB/T16886. 1-1997). The following experiments were conducted: (1)Cytotoxicity, (2)Systemic toxicity(acute toxicity), (3)Haemocompatibility, (4)Sensitization, (5)Intracutaneous reactivity, (6)Pyrogen test, (7)Genotoxicity. The experiment results demonstrate that all biological functional indexes of the Artificial Skin Graft meet the National Standards. Therefore, we conclude that C-C Artificial Skin Graft is characteristic of good biological compatibility. It is non-irritant and has no systemic and cellular toxicity, no genotoxicity, no pyrogen, and no allergen.
Animals ; Chitosan ; toxicity ; Collagen ; toxicity ; Female ; Male ; Materials Testing ; Mice ; Random Allocation ; Skin, Artificial ; adverse effects